Group 1 - The stock of Priority Technology (PRTH) closed at $6.71, with a 2.1% gain over the past four weeks, and analysts set a mean price target of $12.80, indicating a potential upside of 90.8% [1] - The mean estimate consists of five short-term price targets with a standard deviation of $2.77, where the lowest estimate is $10 (49% increase) and the highest is $16 (138.5% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements [11][12] Group 2 - The Zacks Consensus Estimate for the current year has increased by 1.9% over the past month, indicating positive sentiment among analysts [12] - PRTH holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of the stock's potential gain, it suggests a positive direction for price movement [13]

Group 1 - Adeia (ADEA) shares have increased by 4.4% over the past four weeks, closing at $13.10, with a mean price target of $17.33 indicating a potential upside of 32.3% [1] - The average price targets range from a low of $17 to a high of $18, with a standard deviation of $0.58, suggesting a relatively high agreement among analysts [2] - Analysts are optimistic about ADEA's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] Group 2 - The Zacks Consensus Estimate for ADEA's current year earnings has increased by 1% over the past month, with no negative revisions [12] - ADEA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - While consensus price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [13]

Core Viewpoint - Novo Nordisk (NVO) shows potential for significant upside, with a mean price target of $102.16 indicating a 51.2% upside from the current price of $67.55 [1] Price Targets and Analyst Consensus - The average price target consists of nine estimates ranging from $61 to $160, with a standard deviation of $36.83, indicating variability among analysts [2] - The lowest estimate suggests a decline of 9.7%, while the highest points to a 136.9% upside [2] - Analysts' price targets should be approached with caution, as their reliability has been questioned [3][7] Earnings Estimates and Market Sentiment - Analysts are optimistic about NVO's earnings prospects, with a trend of upward revisions in EPS estimates, which historically correlates with stock price movements [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 2.4%, with three estimates moving higher and no negative revisions [12] - NVO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does suggest a positive direction for price movement [13]

Group 1 - Si-Bone (SIBN) shares have increased by 25.5% over the past four weeks, closing at $17.47, with a mean price target of $24.67 indicating a potential upside of 41.2% [1] - The mean estimate consists of nine short-term price targets with a standard deviation of $3.57, where the lowest estimate is $19 (an 8.8% increase) and the highest is $32 (an 83.2% increase) [2] - Analysts show strong agreement on SIBN's ability to report better earnings, with a positive trend in earnings estimate revisions correlating with potential stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for SIBN has increased by 7% due to four upward revisions in earnings estimates over the last 30 days, with no negative revisions [12] - SIBN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - While price targets can be misleading, the direction implied by them may serve as a useful guide for further research into SIBN's fundamentals [10][11]

Core Viewpoint - Deluxe (DLX) shares have increased by 7.4% over the past four weeks, closing at $15.23, with a mean price target of $27.60 indicating a potential upside of 81.2% [1] Price Targets and Analyst Consensus - The average price target consists of five estimates ranging from a low of $23 to a high of $32, with a standard deviation of $3.65, suggesting a potential increase of 51% to 110.1% from the current price [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about DLX's earnings prospects, as evidenced by a positive trend in earnings estimate revisions, which correlates with near-term stock price movements [11] - Over the last 30 days, one earnings estimate has increased, leading to a 5.1% rise in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - DLX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside in the near term [13]

The average comprises 15 short-term price targets ranging from a low of $12 to a high of $20, with a standard deviation of $2.72. While the lowest estimate indicates an increase of 15.9% from the current price level, the most optimistic estimate points to a 93.2% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts. Evolent Health (EVH) closed the last tr ...

Confluent (CFLT) closed the last trading session at $19.73, gaining 0.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $28.45 indicates a 44.2% upside potential. The average comprises 29 short-term price targets ranging from a low of $22 to a high of $36, with a standard deviation of $3.47. While the lowest estimate indicates an increase of 11.5% from the current price level, the ...

Core Viewpoint - Interpublic Group (IPG) shares have increased by 9.2% recently, with a mean price target of $31.38 suggesting a potential upside of 25.4% from the current price of $25.03 [1] Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $3.58, indicating variability among analysts [2] - The lowest price target is $27, suggesting a 7.9% increase, while the highest target is $35, indicating a potential surge of 39.8% [2] - A low standard deviation signifies strong agreement among analysts regarding the stock's price direction [9] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about IPG's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 0.6%, with two estimates moving higher and no negative revisions [12] - IPG holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13]

TTM Technologies (TTMI) closed the last trading session at $25.13, gaining 43% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $35 indicates a 39.3% upside potential. The mean estimate comprises four short-term price targets with a standard deviation of $1.41. While the lowest estimate of $33 indicates a 31.3% increase from the current price level, the most optimistic analyst expec ...

Shares of Celsius Holdings Inc. (CELH) have gained 4.8% over the past four weeks to close the last trading session at $35.52, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $44.63 indicates a potential upside of 25.7%. The average comprises 16 short-term price targets ranging from a low of $30 to a high of $58, with a standard deviation of $7.44. While the lowest estimate indic ...